All News

New Online Tool Calculates Percentiles for 30-Year Cardiovascular Disease Risk in Younger Adults
November 18, 2025

Northwestern University unveils a groundbreaking online tool that helps younger adults understand their 30-year cardiovascular disease risk through percentile rankings.

How Neurodivergent Adults View Neurodiversity Terminology: Findings From a Large UK Survey
November 18, 2025

UK neurodivergent adults report strong views on neurodiversity terminology, emphasizing correct usage and its role in stigma, identity, and communication.

Preventive Health Inventory Boosts Diabetes and Hypertension Management Without Increasing Hospitalizations Among Veterans: New Study
November 18, 2025

A new study reveals that the Preventive Health Inventory enhances diabetes and hypertension management among veterans without increasing hospitalizations.

For GLP-1 Medication Users, Investigational NK-1 Agent May Quell GI Side Effects by Half
November 18, 2025

In the phase 2 clinical trial, tradipitant, an oral neurokinin-1 receptor antagonist, was dosed twice daily among adults with obesity and treated with semaglutide.

Chronic Pain Linked to Greater Risk of Hypertension, Depression Mediates the Relationship
November 17, 2025

Individuals who have chronic widespread pain showed a 75% increased risk of developing hypertension compared to fellow UK Biobank participants who were pain-free.

Alcohol Use at Any Level Tied to Increased Risk of Dementia: Daily Dose
November 17, 2025

Your daily dose of the clinical news you may have missed.

Lisa Larkin, MD, on the Importance of Recognizing and Managing Vasomotor Symptoms in Menopause
November 17, 2025

Women increasingly seek evidence-based menopause care as awareness grows, yet many still suffer from untreated vasomotor symptoms.

Migraine Risk Rises With Unexpectedness of Daily Experiences, the "Surprisal" Factor
November 17, 2025

Higher surprisal scores, measuring how atypical a daily experience is, increased migraine odds by 86% at 12 hours and 115% at 24 hours in new cohort study.

FDA Accepts sNDA for Roflumilast Cream 0.3% to Treat Plaque Psoriasis in Children Aged 2 to 5 Years
November 17, 2025

FDA reviews roflumilast cream for young children with plaque psoriasis, potentially offering a first-of-its-kind topical treatment option.

Tralokinumab Looks Promising to Treat Hand Involvement in Atopic Dermatitis
November 17, 2025

LEO Pharma reveals promising 32-week results for tralokinumab, showing significant benefits for adults with moderate-to-severe hand eczema.